Position in CYTK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$75,911,698
+$48,902,837 QoQ
Shares Held
891,087
+117.5% QoQ
Ownership
0.641%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#40
of 477 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. CYTK ranks #24 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in CYTK
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $75,911,698 | 891,087 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $27,008,861 | 409,784 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $26,050,763 | 409,990 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $22,518,484 | 409,725 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $13,308,147 | 402,789 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $21,607,106 | 537,624 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $25,675,042 | 545,813 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $28,324,399 | 536,447 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $21,864,932 | 403,561 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $39,632,899 | 565,296 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $55,160,339 | 660,682 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $33,321,852 | 1,131,088 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $36,540,434 | 1,120,185 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $38,168,621 | 1,084,644 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $50,678,751 | 1,106,040 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $53,695,777 | 1,108,272 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $42,966,756 | 1,093,580 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $40,191,808 | 1,091,872 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $47,360,946 | 1,039,073 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $35,741,679 | 1,000,047 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||